The sixth forum on international communication of China's rule of law was held in Beijing on Saturday, with participants calling for coordinated efforts to enhance the international discourse of foreign-related rule of law.
Over 50 professionals and experts from institutions, universities, and media gathered at the forum to discuss foreign-related rule of law, strategies and capacity-building in international communication.
They called for enhanced and innovative discourse, high-quality talent and platforms, and cross-sector cooperation.
The forum also released a blue book summarizing foreign-related legal work and research over the past year.
Forum on foreign-related rule of law calls for enhanced international discourse
China on Sunday unveiled an updated version of its national medical insurance drug list and the inaugural edition of the commercial insurance innovative drug list, according to the National Healthcare Security Administration.
The updated national medical insurance drug list has added 114 drugs, among which 50 are innovative pharmaceuticals. It has incorporated certain medications that fill the gaps in basic medical insurance coverage, such as drugs for major diseases, rare diseases, and chronic conditions.
The commercial insurance innovative drug list included 19 drugs for the treatment of tumors, rare diseases, and Alzheimer's, among others.
The country's medical insurance authority has adjusted the list for eight years in a row, increasing the total number of medications to 3,253 and significantly improving coverage in key areas such as oncology, chronic diseases, mental illnesses, rare diseases, and pediatric medications.
China updates national medical insurance catalog, adds 114 new drugs
